Références

Information sur le cancer / Types de cancer / Neuroendocrinien / Traitement / Traitement médicamenteux

Cancer Care Ontario. (2013, March). Drug Monograph: Octreotide. Extrait de: https://www.cancercare.on.ca/toolbox/drugformulary/.

Cancer Care Ontario. (2015, August). Drug Monograph: Interferon Alfa-2B. Extrait de: https://www.cancercare.on.ca/toolbox/drugformulary/.

Cancer Care Ontario. (2015, February). Drug Monograph: Sunitinib. Extrait de: https://www.cancercare.on.ca/toolbox/drugformulary/.

Cancer Care Ontario. (2015, January). Drug Monograph: Everolimus. Extrait de: https://www.cancercare.on.ca/toolbox/drugformulary/.

Carcinoid Neuroendocrine Tumour Society (CNETS) Canada. (2013). Neuroendocrine Tumours: Reference Guide for Patients and Families. Extrait de: http://cnetscanada.org/patients-caregivers/resources/neuroendocrine-tumour-reference-guide-for-patients-and-families/.

Carcinoid Neuroendocrine Tumour Society (CNETS) Canada. (2015, December 8). Approved NET Treatments, Indications and Funding in Canada. Accessed March 15, 2016.

Health Canada. (2018, February 1). Regulatory Decision summary - Somatuline Autogel. Extrait de: https://hpr-rps.hres.ca/reg-content/regulatory-decision-summary-detail.php?linkID=RDS00331.

Norton JA, Kunz PL. Carcinoid tumors and the carcinoid syndrome. DeVita VT Jr, Lawrence TS, Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Édition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 86:1218-1226.

Singh S, Asa SL, Dey C, et al. Diagnosis and management of gastrointestinal neuroendocrine tumors: an evidence-based Canadian consensus. (2016, June). Cancer Treatment Reviews. 47:32-45. Extrait de: https://cnetscanada.org/wp-content/uploads/2016/06/Dx-and-Mgmt-of-GI-NETS_Cancer-Treatment-Reviews.pdf.

Yao JC, Evans DB. Pancreatic neuroendocrine tumors. DeVita VT Jr, Lawrence TS, Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Édition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 85:1205-1217.

Yao JC, Lagunes DR, Kulke MH. Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned. (2013). Oncologist. 18:525-532. Extrait de: http://theoncologist.alphamedpress.org/content/18/5/525.long.

×
×